Geode Capital Management, LLC Delcath Systems, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 703,171 shares of DCTH stock, worth $7.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
703,171
Previous 308,269
128.1%
Holding current value
$7.65 Million
Previous $3.92 Million
143.71%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding DCTH
# of Institutions
121Shares Held
13.2MCall Options Held
105KPut Options Held
38.7K-
Vanguard Group Inc Valley Forge, PA1.61MShares$17.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$8.84 Million0.25% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il803KShares$8.74 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$6.2 Million1.64% of portfolio
-
Marshall Wace, LLP London, X0483KShares$5.26 Million0.01% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $93.5M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...